Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gary R. Haggan"'
Publikováno v:
Journal of Chromatography A. 764:233-241
CP-93,393-1 is a new chemical entity under development for the treatment of anxiety and depression. This paper describes the selection and validation of a chromatographic system which was engineered to: (1) ensure acceptability by world-wide regulato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86adb2c20988b53dcce726df0ae51bfc
https://doi.org/10.1016/s0021-9673(96)00898-9
https://doi.org/10.1016/s0021-9673(96)00898-9
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 14:825-833
5-Chlorooxindole (5-CO) is a starting material for tenidap sodium, a pharmaceutical drug candidate produced by Pfizer. To insure potency and purity of the drug substance, it is necessary to demonstrate that commercial supplies of 5-CO are free from e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::570dc9e0321e865da406bbd91b4e932f
https://doi.org/10.1016/0731-7085(95)01712-7
https://doi.org/10.1016/0731-7085(95)01712-7
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 16(6)
A reversed-phase high performance liquid chromatographic (HPLC) assay developed for the CP-93,393-1 drug substance was adapted for use with CP-93,393-1 tablets. Using a novel experimental matrix, validation was performed to obtain linearity, reproduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b342c02c55b5c7abe74d0a84d12d14cc
https://pubmed.ncbi.nlm.nih.gov/9547712
https://pubmed.ncbi.nlm.nih.gov/9547712